Biotron Limited (ASX:BIT)

Biotron Statistics

Total Valuation

Biotron has a market cap or net worth of AUD 7.23 million. The enterprise value is 6.30 million.

Market Cap	7.23M
Enterprise Value	6.30M

Important Dates

The next estimated earnings date is Sunday, February 22, 2026.

Earnings Date	Feb 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Biotron has 2.41 billion shares outstanding. The number of shares has increased by 10.76% in one year.

Current Share Class	2.41B
Shares Outstanding	2.41B
Shares Change (YoY)	+10.76%
Shares Change (QoQ)	+10.51%
Owned by Insiders (%)	22.20%
Owned by Institutions (%)	0.48%
Float	1.71B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.99
PB Ratio	13.10
P/TBV Ratio	13.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-19.76
EV / Sales	3.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.07

Financial Position

The company has a current ratio of 2.23

Current Ratio	2.23
Quick Ratio	2.19
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.16

Financial Efficiency

Return on equity (ROE) is -206.96% and return on invested capital (ROIC) is -134.43%.

Return on Equity (ROE)	-206.96%
Return on Assets (ROA)	-28.73%
Return on Invested Capital (ROIC)	-134.43%
Return on Capital Employed (ROCE)	-61.38%
Weighted Average Cost of Capital (WACC)	-0.85%
Revenue Per Employee	604,543
Profits Per Employee	-106,191
Employee Count	3
Asset Turnover	2.46
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.25% in the last 52 weeks. The beta is -0.93, so Biotron's price volatility has been lower than the market average.

Beta (5Y)	-0.93
52-Week Price Change	-81.25%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	48.30
Average Volume (20 Days)	5,403,460

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotron had revenue of AUD 1.81 million and -318,572 in losses. Loss per share was -0.00.

Revenue	1.81M
Gross Profit	1.81M
Operating Income	-338,751
Pretax Income	-318,572
Net Income	-318,572
EBITDA	-333,806
EBIT	-338,751
Loss Per Share	-0.00

Balance Sheet

The company has 931,676 in cash and n/a in debt, with a net cash position of 931,676 or 0.00 per share.

Cash & Cash Equivalents	931,676
Total Debt	n/a
Net Cash	931,676
Net Cash Per Share	0.00
Equity (Book Value)	551,895
Book Value Per Share	0.00
Working Capital	526,894

Cash Flow

In the last 12 months, operating cash flow was -565,800 and capital expenditures -3,071, giving a free cash flow of -568,871.

Operating Cash Flow	-565,800
Capital Expenditures	-3,071
Free Cash Flow	-568,871
FCF Per Share	-0.00

Margins

Gross margin is 100.00%, with operating and profit margins of -18.68% and -17.57%.

Gross Margin	100.00%
Operating Margin	-18.68%
Pretax Margin	-17.57%
Profit Margin	-17.57%
EBITDA Margin	-18.41%
EBIT Margin	-18.68%
FCF Margin	n/a

Dividends & Yields

Biotron does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.76%
Shareholder Yield	-10.76%
Earnings Yield	-4.41%
FCF Yield	-7.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotron has an Altman Z-Score of -62.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-62.27
Piotroski F-Score	2